Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Jazz Pharmaceuticals plc

8.7% sales growth and 5.57% return on equity

Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally.

Jazz Pharmaceuticals plc’s sales growth this year is anticipated to be 8.1% and 8.6% for next year.

Year-on-year quarterly revenue growth grew by 11.8%, now sitting on 2.28B for the twelve trailing months.

Jazz Pharmaceuticals plc’s sales growth for the next quarter is 8.7%. The company’s growth estimates for the current quarter and the next is a negative 3.6% and 662.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.57%.

Volatility

Jazz Pharmaceuticals plc’s last day, last week, and last month’s average volatility was a negative 0.95%, a negative 0.45%, and a positive 0.39%, respectively.

Jazz Pharmaceuticals plc’s last day, last week, and last month’s high and low average amplitude percentage was 3.17%, 2.77%, and 2.88%, respectively.

Jazz Pharmaceuticals plc’s Stock Yearly Top and Bottom Value

Jazz Pharmaceuticals plc’s stock is valued at $164.12 at 13:22 EST, below its 52-week high of $166.98 and way above its 52-week low of $86.88.

Jazz Pharmaceuticals plc’s Moving Average

Jazz Pharmaceuticals plc’s value is higher than its 50-day moving average of $152.08 and way higher than its 200-day moving average of $136.61.

2. Kimball Electronics, Inc.

9.2% sales growth and 7.38% return on equity

Kimball Electronics, Inc. provides contract electronics manufacturing services and diversified manufacturing services to customers in the automotive, medical, industrial, and public safety end markets.

Kimball Electronics, Inc.’s sales growth this year is expected to be 7.8% and 5.4% for next year.

Year-on-year quarterly revenue growth grew by 5.9%, now sitting on 1.22B for the twelve trailing months.

Kimball Electronics, Inc.’s sales growth is a negative 0% for the ongoing quarter and 9.2% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 0% and 44%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.38%.

Volatility

Kimball Electronics, Inc.’s last day, last week, and last month’s average volatility was a negative 2.05%, a positive 1.39%, and a positive 0.34%, respectively.

Kimball Electronics, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 3.29%, 3.34%, and 2.88%, respectively.

Kimball Electronics, Inc.’s Stock Yearly Top and Bottom Value

Kimball Electronics, Inc.’s stock is valued at $17.23 at 13:22 EST, under its 52-week high of $18.00 and way higher than its 52-week low of $9.78.

Kimball Electronics, Inc.’s Moving Average

Kimball Electronics, Inc.’s worth is higher than its 50-day moving average of $15.94 and way higher than its 200-day moving average of $13.75.

3. STAAR Surgical Company

26.2% sales growth and 5.34% return on equity

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye.

STAAR Surgical Company’s sales growth this year is anticipated to be 7.4% and 26.8% for next year.

Year-on-year quarterly revenue growth grew by 20.6%, now sitting on 156.34M for the twelve trailing months.

STAAR Surgical Company’s sales growth for the next quarter is 26.2%. The company’s growth estimates for the current quarter and the next is a negative 85.7% and negative 0%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.34%.

Volatility

STAAR Surgical Company’s last day, last week, and last month’s average volatility was a negative 0.50%, a positive 0.59%, and a positive 0.38%, respectively.

STAAR Surgical Company’s last day, last week, and last month’s high and low average amplitude percentage was 4.70%, 5.10%, and 5.31%, respectively.

STAAR Surgical Company’s Stock Yearly Top and Bottom Value

STAAR Surgical Company’s stock is valued at $89.37 at 13:22 EST, under its 52-week high of $89.96 and way higher than its 52-week low of $23.20.

STAAR Surgical Company’s Moving Average

STAAR Surgical Company’s worth is way above its 50-day moving average of $77.98 and way above its 200-day moving average of $64.25.

4. Meridian Corporation

33.8% sales growth and 16.49% return on equity

Meridian Corporation operates as the bank holding for Meridian Bank that provides commercial banking products and services for small and middle market businesses primarily in southeast Pennsylvania, Delaware, and southern New Jersey.

Meridian Corporation’s sales growth this year is anticipated to be 77.7% and a negative 14% for next year.

Year-on-year quarterly revenue growth grew by 112.7%, now sitting on 103.95M for the twelve trailing months.

Meridian Corporation’s sales growth for the next quarter is 33.8%. The company’s growth estimates for the current quarter and the next is 71.4% and 87.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.49%.

Volatility

Meridian Corporation’s last day, last week, and last month’s average volatility was a negative 2.87%, a negative 0.53%, and a positive 0.44%, respectively.

Meridian Corporation’s last day, last week, and last month’s high and low average amplitude percentage was 5.69%, 4.87%, and 6.18%, respectively.

Meridian Corporation’s Stock Yearly Top and Bottom Value

Meridian Corporation’s stock is valued at $20.22 at 13:22 EST, way under its 52-week high of $26.00 and way above its 52-week low of $10.68.

Meridian Corporation’s Moving Average

Meridian Corporation’s value is below its 50-day moving average of $20.23 and way above its 200-day moving average of $17.00.

5. Installed Building Products, Inc.

14.7% sales growth and 33.33% return on equity

Installed Building Products, Inc., together with its subsidiaries, engages in the installation of insulation, waterproofing, fire-stopping, fireproofing, garage doors, rain gutters, window blinds, shower doors, closet shelving and mirrors, and other products in the continental United States.

Installed Building Products, Inc.’s sales growth this year is expected to be 9.7% and 15.4% for next year.

Year-on-year quarterly revenue growth grew by 6.1%, now sitting on 1.61B for the twelve trailing months.

Installed Building Products, Inc.’s sales growth for the next quarter is 14.7%. The company’s growth estimates for the ongoing quarter and the next is 33.7% and 39.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 33.33%.

Volatility

Installed Building Products, Inc.’s last day, last week, and last month’s average volatility was a negative 5.91%, a positive 0.89%, and a positive 0.68%, respectively.

Installed Building Products, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 6.95%, 5.35%, and 4.00%, respectively.

Installed Building Products, Inc.’s Stock Yearly Top and Bottom Value

Installed Building Products, Inc.’s stock is valued at $106.59 at 13:22 EST, way below its 52-week high of $121.67 and way above its 52-week low of $29.02.

Installed Building Products, Inc.’s Moving Average

Installed Building Products, Inc.’s worth is higher than its 50-day moving average of $101.38 and way above its 200-day moving average of $93.00.

6. Arch Capital Group Ltd.

11.8% sales growth and 9.31% return on equity

Arch Capital Group Ltd., together with its subsidiaries, provides insurance, reinsurance, and mortgage insurance products worldwide.

Arch Capital Group Ltd.’s sales growth this year is expected to be 23.6% and 13.6% for next year.

Year-on-year quarterly revenue growth grew by 37.5%, now sitting on 7.88B for the twelve trailing months.

Arch Capital Group Ltd.’s sales growth for the next quarter is 11.8%. The company’s growth estimates for the ongoing quarter and the next is a negative 36.5% and 43.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.31%.

Volatility

Arch Capital Group Ltd.’s last day, last week, and last month’s average volatility was 0.55%, 0.21%, and 0.45%, respectively.

Arch Capital Group Ltd.’s last day, last week, and last month’s high and low average amplitude percentage was 2.30%, 3.29%, and 2.80%, respectively.

Arch Capital Group Ltd.’s Stock Yearly Top and Bottom Value

Arch Capital Group Ltd.’s stock is valued at $36.44 at 13:22 EST, way below its 52-week high of $48.32 and way above its 52-week low of $20.93.

Arch Capital Group Ltd.’s Moving Average

Arch Capital Group Ltd.’s worth is higher than its 50-day moving average of $34.45 and way higher than its 200-day moving average of $31.69.

LEAVE A REPLY

Please enter your comment!
Please enter your name here